I-Mab (IMAB)
USD 0.92
(-2.71%)
USD 0.92
(-2.71%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2 Billion CNY | 36.04% |
| 2022 | -3.13 Billion CNY | 7.98% |
| 2021 | -3.41 Billion CNY | 28.11% |
| 2020 | -4.74 Billion CNY | -372.17% |
| 2019 | -1 Billion CNY | 30.27% |
| 2018 | -1.44 Billion CNY | -1418.34% |
| 2017 | -94.92 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -1.07 Billion CNY | 0.0% |
| 2023 FY | -2 Billion CNY | 36.04% |
| 2023 Q3 | -2.08 Billion CNY | 8.48% |
| 2023 Q2 | -2.28 Billion CNY | 1.18% |
| 2023 Q1 | -2.3 Billion CNY | 26.44% |
| 2023 Q4 | -2 Billion CNY | 3.87% |
| 2022 FY | -3.13 Billion CNY | 7.98% |
| 2022 Q3 | -3.16 Billion CNY | 12.31% |
| 2022 Q1 | -3.64 Billion CNY | -6.99% |
| 2022 Q2 | -3.6 Billion CNY | 1.17% |
| 2022 Q4 | -3.13 Billion CNY | 0.76% |
| 2021 Q1 | -4.31 Billion CNY | 9.16% |
| 2021 FY | -3.41 Billion CNY | 28.11% |
| 2021 Q4 | -3.41 Billion CNY | 0.89% |
| 2021 Q2 | -4.3 Billion CNY | 0.23% |
| 2021 Q3 | -3.44 Billion CNY | 19.97% |
| 2020 Q4 | -4.74 Billion CNY | -64.64% |
| 2020 Q3 | -2.88 Billion CNY | -95.34% |
| 2020 Q2 | -1.47 Billion CNY | 0.55% |
| 2020 Q1 | -1.48 Billion CNY | -47.63% |
| 2020 FY | -4.74 Billion CNY | -372.17% |
| 2019 Q3 | -1.09 Billion CNY | 4.09% |
| 2019 Q2 | -1.13 Billion CNY | 0.48% |
| 2019 Q1 | -1.14 Billion CNY | 20.53% |
| 2019 Q4 | -1 Billion CNY | 8.07% |
| 2019 FY | -1 Billion CNY | 30.27% |
| 2018 Q1 | 574.17 Million CNY | 0.0% |
| 2018 FY | -1.44 Billion CNY | -1418.34% |
| 2018 Q4 | -1.44 Billion CNY | 0.0% |
| 2017 FY | -94.92 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -26760.082% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 1321.389% |
| IO Biotech, Inc. | -140.69 Million USD | -1326.857% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -6490.85% |
| Organovo Holdings, Inc. | -1.5 Million USD | -133116.523% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -76171.513% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -168868.425% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -13164.44% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -3493.679% |
| Savara Inc. | 153 Thousand USD | 1312239.216% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -8698.97% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -6405.0% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 28911.009% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -64059.842% |
| Soligenix, Inc. | -4.95 Million USD | -40443.95% |
| Aptose Biosciences Inc. | -8.19 Million USD | -24397.963% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 10319.257% |
| Century Therapeutics, Inc. | 847 Thousand USD | 237121.606% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 5958.448% |
| Precision BioSciences, Inc. | -85.41 Million USD | -2250.513% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -904.686% |
| Kura Oncology, Inc. | -20.11 Million USD | -9878.989% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -22248.466% |
| Dyadic International, Inc. | -6.37 Million USD | -31376.04% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -4805.373% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -1202.384% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -62695.527% |
| Autolus Therapeutics plc | -186.59 Million USD | -975.876% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -12500.094% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | -627.925% |
| GRI Bio, Inc. | -1.79 Million USD | -111804.849% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -5936.543% |
| IGM Biosciences, Inc. | -72.6 Million USD | -2665.024% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 1429.95% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -3862.914% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -69488.371% |
| Opthea Limited | 28.15 Million USD | 7229.812% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -4774.525% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 6396.293% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -3770.99% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -11857.669% |
| Surrozen, Inc. | -32.66 Million USD | -6046.133% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -47659.694% |
| Cingulate Inc. | 3.08 Million USD | 65224.212% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 10688.349% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 1910.745% |
| Acelyrin, Inc. | -216.9 Million USD | -825.563% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -4521.272% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -13672.328% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | -533.726% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -2492.056% |
| ADMA Biologics, Inc. | 90.06 Million USD | 2329.002% |
| PureTech Health plc | -167.19 Million USD | -1100.723% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -31371.594% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -26970.833% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -1454.884% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -7837.581% |
| Synaptogenix, Inc. | -28.66 Million USD | -6904.425% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -214384.295% |
| ChromaDex Corporation | -24.04 Million USD | -8248.191% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -23399.141% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -27529.382% |
| Exelixis, Inc. | -73.05 Million USD | -2648.218% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 3377.296% |
| Better Therapeutics, Inc. | -860 Thousand USD | -233338.721% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -8260.359% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -731.737% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -28175.676% |
| Seer, Inc. | -4.24 Million USD | -47248.42% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 160193.541% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -5194.512% |
| Gritstone bio, Inc. | 39.49 Million USD | 5183.75% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -2287.098% |
| Avid Bioservices, Inc. | 169.72 Million USD | 1282.818% |
| Insmed Incorporated | 721.62 Million USD | 378.204% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 76842.087% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -57046.968% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 3355.559% |
| MediWound Ltd. | -5.32 Million USD | -37622.153% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 5651.456% |
| Fortress Biotech, Inc. | 7.66 Million USD | 26291.429% |
| OmniAb, Inc. | 9.2 Million USD | 21914.332% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 2435.175% |
| Zai Lab Limited | -775 Million USD | -159.042% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 689.5% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -939.036% |
| Veracyte, Inc. | -203.82 Million USD | -884.954% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -22026.893% |
| FibroGen, Inc. | 56.76 Million USD | 3636.514% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -1626.469% |
| ContextLogic Inc. | -232 Million USD | -765.333% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -23805.37% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -70912.196% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -1716.2% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 143.735% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 319777.229% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -59988.985% |
| ImmuCell Corporation | 10.99 Million USD | 18366.336% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 227.92% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -8103.551% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -2287.098% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -5593.143% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -1078.049% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 35376.278% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -2073.31% |
| Vaxxinity, Inc. | 10.13 Million USD | 19914.183% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 372.67% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -18544.657% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -58045.472% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -13185.112% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 48405.414% |
| Senti Biosciences, Inc. | 1.74 Million USD | 115477.759% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -277934.097% |
| Apollomics, Inc. | -27.39 Million USD | -7228.246% |
| 89bio, Inc. | -289.05 Million USD | -594.535% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 47005.911% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -86544.351% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -4848.174% |
| Ardelyx, Inc. | 34.51 Million USD | 5917.029% |
| Pluri Inc. | 22.82 Million USD | 8893.959% |
| Prothena Corporation plc | -608.34 Million USD | -230.005% |
| Pulmatrix, Inc. | -10.41 Million USD | -19172.084% |
| Celularity Inc. | 65.19 Million USD | 3179.572% |
| MeiraGTx Holdings plc | -40.3 Million USD | -4881.324% |
| Omeros Corporation | 331.17 Million USD | 706.195% |
| Ainos, Inc. | 4.07 Million USD | 49330.222% |
| Humacyte, Inc. | -22.48 Million USD | -8828.102% |
| Mesoblast Limited | 55.96 Million USD | 3687.322% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -8069.168% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -6396.79% |
| Blueprint Medicines Corporation | 702.83 Million USD | 385.639% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -966.61% |
| Summit Therapeutics Inc. | 34.67 Million USD | 5889.851% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -33017.338% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -4914.294% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -1702.098% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -3249.08% |
| Cytokinetics, Incorporated | 642.37 Million USD | 412.525% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -34376.61% |
| Nutriband Inc. | -251.65 Thousand USD | -797641.768% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -5784.032% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 66.74% |
| Evogene Ltd. | -19.63 Million USD | -10124.982% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -4024.698% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -21633.597% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 247.193% |
| BioLineRx Ltd. | 7.33 Million USD | 27466.044% |
| Atai Life Sciences N.V. | -28.55 Million USD | -6929.81% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -1615.2% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 4219.62% |
| MediciNova, Inc. | -50.78 Million USD | -3853.198% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -2447.52% |
| MiMedx Group, Inc. | -33.9 Million USD | -5821.87% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -1021.706% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -2016.711% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | -583.408% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -12254.773% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 44067.871% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -756.338% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -2030.933% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -1997.865% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -5038.006% |
| Allakos Inc. | -24.97 Million USD | -7938.33% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -13518.05% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -1382.698% |
| BioAtla, Inc. | -109.01 Million USD | -1741.624% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 16877.311% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -9368.344% |
| Precigen, Inc. | -481 Thousand USD | -417274.844% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -232773.056% |
| XOMA Corporation | -29 Million USD | -6822.666% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -12023.025% |
| Incyte Corporation | -3.17 Billion USD | 36.771% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -22166.781% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -1510.749% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -10740.111% |
| CRISPR Therapeutics AG | -150.84 Million USD | -1230.885% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -864.419% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -2064.196% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -233560.427% |
| UroGen Pharma Ltd. | 4.39 Million USD | 45820.178% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 1869.083% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 2789868.211% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -8907.417% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -987.485% |
| Chimerix, Inc. | -25.51 Million USD | -7767.59% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 16605.212% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -101816.985% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -3309.89% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -9191.386% |
| Portage Biotech Inc. | -4.98 Million USD | -40204.618% |
| OncoCyte Corporation | -6.56 Million USD | -30489.258% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 223806.699% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -23853.431% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -43967.83% |
| Purple Biotech Ltd. | -14.13 Million USD | -14099.837% |
| NextCure, Inc. | -6.47 Million USD | -30895.415% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -11927.038% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -26890.274% |
| Generation Bio Co. | 31.44 Million USD | 6483.786% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | -444.342% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 1341.219% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -26329.344% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 272843.613% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -3971.826% |
| Novavax, Inc. | -298.29 Million USD | -573.018% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -60424.742% |
| Curis, Inc. | -23.88 Million USD | -8304.458% |
| Daré Bioscience, Inc. | -5.15 Million USD | -38822.211% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -32238.483% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -21861.061% |
| Bicycle Therapeutics plc | -481.46 Million USD | -316.97% |
| BeiGene, Ltd. | -2.25 Billion USD | 10.897% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 16370.803% |
| Alector, Inc. | -35.63 Million USD | -5533.395% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -981.748% |
| Erasca, Inc. | -37.21 Million USD | -5294.381% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -40638.088% |
| Aura Biosciences, Inc. | -21.52 Million USD | -9226.704% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 15264.083% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -22265.877% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -155780.419% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -11440.429% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 630.055% |
| Histogen Inc. | -7.48 Million USD | -26714.118% |
| Fortress Biotech, Inc. | 7.66 Million USD | 26291.429% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -1045.679% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -2334.012% |
| Galecto, Inc. | -21.21 Million USD | -9362.542% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 414.522% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -728.333% |
| Molecular Templates, Inc. | 707 Thousand USD | 284056.577% |
| PDS Biotechnology Corporation | -32.7 Million USD | -6037.696% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -1109.644% |
| Amarin Corporation plc | -191.04 Million USD | -950.865% |
| TG Therapeutics, Inc. | 17.86 Million USD | 11339.352% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -17346.537% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -6120.789% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -5740.042% |
| Onconetix, Inc. | 5.33 Million USD | 37755.383% |
| MacroGenics, Inc. | -66.98 Million USD | -2897.049% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -2499.877% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -3875.313% |
| Adagene Inc. | -87.62 Million USD | -2191.034% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -2861.765% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -2943.806% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -4038.558% |
| SciSparc Ltd. | -2.06 Million USD | -97119.031% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -16641.353% |
| Minerva Neurosciences, Inc. | 41 Million USD | 4996.012% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -1044.803% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -6392.168% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 1821.864% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -2123.965% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 207.36% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 29218.057% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -29314.989% |
| 2seventy bio, Inc. | 181.71 Million USD | 1204.792% |
| Clene Inc. | 3.34 Million USD | 60206.976% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -9232.774% |
| GeoVax Labs, Inc. | -6.45 Million USD | -31012.674% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -96867.901% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -11330.044% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -1611437.628% |
| Absci Corporation | -72.59 Million USD | -2665.328% |
| XBiotech Inc. | -200.02 Million USD | -903.671% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -38440.468% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 44436.86% |
| Entera Bio Ltd. | -10.62 Million USD | -18787.694% |
| Trevena, Inc. | 2.25 Million USD | 89009.345% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -1590.502% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -8379.001% |
| INmune Bio, Inc. | -25.41 Million USD | -7800.409% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -7621.529% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -3797.443% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -68254.545% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 28033.394% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -21507.189% |
| Jaguar Health, Inc. | 29.39 Million USD | 6930.571% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 14357.318% |
| NexImmune, Inc. | -3.13 Million USD | -63965.147% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -1802.156% |
| Clearmind Medicine Inc. | -3.94 Million USD | -50819.55% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -819625.366% |
| Kronos Bio, Inc. | -36.05 Million USD | -5468.239% |
| Innoviva, Inc. | 255.56 Million USD | 885.549% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 631.173% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -7308.018% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 21436.731% |
| Verastem, Inc. | -37.27 Million USD | -5285.41% |
| ProKidney Corp. | -56.23 Million USD | -3469.907% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 137781.629% |
| Imunon, Inc. | -4.21 Million USD | -47542.229% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -3600.186% |
| Statera Biopharma, Inc. | 14.41 Million USD | 14025.614% |
| ImmunityBio, Inc. | 618.22 Million USD | 424.732% |
| Korro Bio, Inc. | -132.94 Million USD | -1410.101% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 679.206% |
| Kineta, Inc. | -4.54 Million USD | -44109.932% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -1397.306% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -22003.255% |
| GT Biopharma, Inc. | -1.02 Million USD | -196528.11% |
| Keros Therapeutics, Inc. | -316.7 Million USD | -533.898% |
| Celularity Inc. | 65.19 Million USD | 3179.572% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -63250.363% |
| CalciMedica, Inc. | -5.53 Million USD | -36203.309% |
| Cibus, Inc. | -8.07 Million USD | -24752.352% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -3509.834% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -19555.111% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -47371.577% |
| Kodiak Sciences Inc. | -103.87 Million USD | -1832.682% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -5937.269% |
| Annexon, Inc. | -193.75 Million USD | -936.14% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 5576691.667% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -11372.501% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -33488.305% |
| Moderna, Inc. | -2.9 Billion USD | 30.94% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -5163.418% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 290.422% |
| Vor Biopharma Inc. | 4.3 Million USD | 46787.744% |
| Eyenovia, Inc. | 1.25 Million USD | 159595.496% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -48356.988% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 7561.71% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -2346.41% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -1093.329% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -61804.81% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -1427.229% |
| Immunocore Holdings plc | -358.59 Million USD | -459.846% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -7209.569% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 4450.387% |
| Alkermes plc | -166.73 Million USD | -1104.021% |
| Arcellx, Inc. | -296.95 Million USD | -576.046% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 90104.344% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 11419.836% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -2574.126% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -9585.787% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -8924429.896% |
| Moolec Science SA | 117.61 Thousand USD | 1706987.668% |
| Biomea Fusion, Inc. | -166.57 Million USD | -1105.243% |
| RenovoRx, Inc. | -1.17 Million USD | -171048.593% |
| Geron Corporation | 14.76 Million USD | 13700.522% |
| Mereo BioPharma Group plc | -51.46 Million USD | -3800.548% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -8252.011% |
| Royalty Pharma plc | 5.65 Billion USD | 135.48% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -1319.572% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -28623.011% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -8340.5% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -37334.753% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -1326.532% |
| Humacyte, Inc. | -22.48 Million USD | -8828.102% |
| Structure Therapeutics Inc. | -124.33 Million USD | -1514.596% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 272843.613% |
| Genelux Corporation | -6.89 Million USD | -28999.478% |
| ESSA Pharma Inc. | -33.62 Million USD | -5871.084% |
| aTyr Pharma, Inc. | -7.44 Million USD | -26850.906% |
| Notable Labs, Ltd. | -9.77 Million USD | -20435.73% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -2664796.328% |
| Mustang Bio, Inc. | -3.73 Million USD | -53635.894% |
| Immunovant, Inc. | -635.22 Million USD | -216.04% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 123803.578% |
| Vericel Corporation | 1.27 Million USD | 157310.102% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 245.384% |
| Akari Therapeutics, Plc | -3.84 Million USD | -52112.562% |
| Acasti Pharma Inc. | -23 Million USD | -8626.681% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -59520.923% |
| Vaxcyte, Inc. | -368.22 Million USD | -445.2% |
| Orgenesis Inc. | 21.78 Million USD | 9315.814% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -2088.568% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -8930.105% |
| GH Research PLC | -78.07 Million USD | -2471.273% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -10711.422% |
| PepGen Inc. | -60.67 Million USD | -3209.004% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -8637.696% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -48966.116% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -232773.056% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -47659.694% |
| Silo Pharma, Inc. | -3.52 Million USD | -56863.608% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 2012321.231% |
| Belite Bio, Inc | -87.27 Million USD | -2200.39% |
| Pharming Group N.V. | 109.8 Million USD | 1928.324% |
| XOMA Corporation | -29 Million USD | -6822.666% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -7430.564% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -10740.111% |
| Bionomics Limited | 227 Million USD | 984.355% |
| Xencor, Inc. | 29.64 Million USD | 6872.274% |
| Replimune Group, Inc. | 1.41 Million USD | 142279.391% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 19791.741% |
| Cassava Sciences, Inc. | -121.13 Million USD | -1557.289% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -1488.056% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -48096.08% |
| Turnstone Biologics Corp. | -14.58 Million USD | -13665.586% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 16146.463% |
| GeoVax Labs, Inc. | -6.45 Million USD | -31012.674% |
| MEI Pharma, Inc. | -3.7 Million USD | -54085.506% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -2936.165% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -8924429.896% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -213699.042% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 1894036.792% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -8350.804% |
| scPharmaceuticals Inc. | -6.54 Million USD | -30573.384% |
| HilleVax, Inc. | -165.48 Million USD | -1113.145% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 25110.253% |
| Tharimmune, Inc. | -10.93 Million USD | -18258.559% |
| Genprex, Inc. | -6.73 Million USD | -29696.431% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 22644.335% |
| Immunic, Inc. | -45.34 Million USD | -4327.819% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -2169.47% |
| Aptorum Group Limited | 1.35 Million USD | 148036.99% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -1085.962% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 22644.335% |
| OKYO Pharma Limited | -826.84 Thousand USD | -242698.314% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -258603.86% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 169515.443% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 110303.574% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 1113.593% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -35683.912% |
| bluebird bio, Inc. | 108.57 Million USD | 1949.088% |
| DBV Technologies S.A. | -126.98 Million USD | -1480.94% |
| Compugen Ltd. | -12.9 Million USD | -15457.757% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -155780.419% |
| Peak Bio, Inc. | 10.34 Million USD | 19515.303% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -19293.093% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -18372.332% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -29410.113% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -6853.356% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -709289.753% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -6299.455% |
| Benitec Biopharma Inc. | -50.58 Million USD | -3868.947% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -1824.105% |
| Adicet Bio, Inc. | -138.78 Million USD | -1346.514% |
| Prime Medicine, Inc. | -27.94 Million USD | -7085.043% |
| Aditxt, Inc. | 18.12 Million USD | 11178.78% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 11719.244% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -48096.08% |
| Quantum-Si incorporated | -118.55 Million USD | -1593.34% |
| GlycoMimetics, Inc. | -40.98 Million USD | -4798.38% |
| PolyPid Ltd. | 6.17 Million USD | 32637.65% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 2808.544% |
| Invivyd, Inc. | -198.47 Million USD | -911.494% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -83629.525% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 7323.304% |
| CorMedix Inc. | -43.05 Million USD | -4563.081% |
| Instil Bio, Inc. | 75.35 Million USD | 2764.048% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | -483.387% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 1229.97% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 40235.406% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -2735.956% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -79156.731% |
| AbCellera Biologics Inc. | -55.94 Million USD | -3488.797% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -1683.431% |
| Surrozen, Inc. | -32.66 Million USD | -6046.133% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 37716.133% |
| Verona Pharma plc | -220.44 Million USD | -810.699% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -2430.884% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -1440.684% |
| Evaxion Biotech A/S | 5.28 Million USD | 38072.995% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -1429.311% |
| Shattuck Labs, Inc. | -121.42 Million USD | -1553.358% |
| AlloVir, Inc. | -62.69 Million USD | -3102.279% |
| BioVie Inc. | -17.73 Million USD | -11221.528% |
| Codexis, Inc. | -43.27 Million USD | -4539.535% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -116348.55% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -168868.425% |
| Agenus Inc. | 274.13 Million USD | 832.327% |
| Virax Biolabs Group Limited | -3.36 Million USD | -59561.409% |
| Lantern Pharma Inc. | -21.7 Million USD | -9150.091% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -2354.876% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 44029.387% |
| Immix Biopharma, Inc. | -17.5 Million USD | -11365.431% |
| Celcuity Inc. | 6.78 Million USD | 29694.904% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -10192.079% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -5128.191% |
| IN8bio, Inc. | -16.38 Million USD | -12149.515% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -112495.233% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -6363.74% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 2501.432% |
| Liquidia Corporation | -80.17 Million USD | -2403.958% |
| Quantum-Si incorporated | -118.55 Million USD | -1593.34% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -12254.773% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -1357.509% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -34158.925% |
| United Therapeutics Corporation | -507.7 Million USD | -295.425% |
| Solid Biosciences Inc. | -47.75 Million USD | -4104.341% |
| Immuneering Corporation | -54.94 Million USD | -3553.929% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -79156.731% |
| uniQure N.V. | -102.95 Million USD | -1850.028% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -5938.358% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -87644.457% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 5002.378% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -14388.835% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -7853.304% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -64320.404% |
| Cue Biopharma, Inc. | -33.81 Million USD | -5836.228% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -10396.565% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -2739.686% |
| Zura Bio Limited | -99.8 Million USD | -1911.475% |
| Forte Biosciences, Inc. | -11.96 Million USD | -16684.324% |
| Elevation Oncology, Inc. | -19.11 Million USD | -10400.957% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -61804.81% |
| Immunome, Inc. | -97.02 Million USD | -1969.044% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -8824.53% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -2698.284% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 12727.532% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -982.255% |
| Altimmune, Inc. | -134.48 Million USD | -1392.764% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 5381.002% |
| Rallybio Corporation | -24.1 Million USD | -8229.487% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -45808.37% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -1423.89% |
| Moolec Science SA | 117.61 Thousand USD | 1706987.668% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -64781.811% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -143195.717% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -1330.802% |
| NeurAxis, Inc. | 145.7 Thousand USD | 1377981.263% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 5675.817% |
| Lumos Pharma, Inc. | -28.49 Million USD | -6945.846% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -2698.284% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -306058.48% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 10319.257% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -9563.955% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 137781.629% |
| Nutriband Inc. | -251.65 Thousand USD | -797641.768% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -26883.508% |
| argenx SE | -2.02 Billion USD | 1.048% |
| Neurogene Inc. | -131.95 Million USD | -1421.407% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 9302.296% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -40795.763% |
| CervoMed Inc. | -7.79 Million USD | -25661.744% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | -432.243% |
| Sesen Bio, Inc. | -112.55 Million USD | -1683.669% |
| AnaptysBio, Inc. | -18.15 Million USD | -10960.399% |
| Design Therapeutics, Inc. | -18.15 Million USD | -10961.008% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -2752.436% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 17973.691% |
| Achilles Therapeutics plc | -126.92 Million USD | -1481.713% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -79000.591% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -15142.373% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 690.121% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 8558.281% |
| MoonLake Immunotherapeutics | -447.47 Million USD | -348.648% |
| Palisade Bio, Inc. | -12.06 Million USD | -16542.402% |
| Beam Therapeutics Inc. | -262.72 Million USD | -664.143% |
| AEON Biopharma, Inc. | -4.88 Million USD | -41038.791% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -1910.388% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -85408.944% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -5044.194% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -2310.573% |
| Athira Pharma, Inc. | -88.99 Million USD | -2155.725% |
| Vaccinex, Inc. | -1.28 Million USD | -155767.469% |
| HCW Biologics Inc. | 2.85 Million USD | 70376.538% |
| XOMA Corporation | -29 Million USD | -6822.666% |
| Nektar Therapeutics | 210.24 Million USD | 1054.896% |
| Arvinas, Inc. | -313.8 Million USD | -539.762% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 123803.578% |
| Merus N.V. | -192.88 Million USD | -940.819% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 3446.792% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -28835.904% |
| Rezolute, Inc. | -68.16 Million USD | -2845.037% |
| Clene Inc. | 3.34 Million USD | 60206.976% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -15123.88% |
| BeyondSpring Inc. | -13.75 Million USD | -14495.224% |
| Synlogic, Inc. | -6.68 Million USD | -29931.01% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 177134.656% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -23644.211% |
| Peak Bio, Inc. | 10.34 Million USD | 19515.303% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -2335.784% |
| Krystal Biotech, Inc. | -350.23 Million USD | -473.209% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 1717.38% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -1087.941% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -63488.262% |
| MannKind Corporation | 143.89 Million USD | 1495.126% |
| Ikena Oncology, Inc. | -109.15 Million USD | -1739.178% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -26416.616% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -5965.175% |
| Gossamer Bio, Inc. | 180.35 Million USD | 1213.123% |
| CohBar, Inc. | -5.93 Million USD | -33750.347% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -6648.598% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 44067.871% |
| Legend Biotech Corporation | -949.39 Million USD | -111.457% |
| Mural Oncology plc | -255.84 Million USD | -684.689% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 6331.796% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -42517.822% |
| Disc Medicine, Inc. | -358.28 Million USD | -460.335% |
| Champions Oncology, Inc. | 4.81 Million USD | 41820.137% |
| REGENXBIO Inc. | 54.76 Million USD | 3765.595% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -746467.773% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -1229.307% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -22176.65% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -2388.223% |
| Vaxart, Inc. | -8.24 Million USD | -24260.794% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -3900.746% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -1478.707% |
| Cellectis S.A. | -43.85 Million USD | -4477.752% |
| Longeveron Inc. | -2.9 Million USD | -68936.21% |
| Repare Therapeutics Inc. | -107.85 Million USD | -1761.311% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 307.313% |
| Inozyme Pharma, Inc. | 12 Million USD | 16824.2% |
| Revolution Medicines, Inc. | -608.2 Million USD | -230.082% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -163117.317% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | -657.24% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -1237.74% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -12730.402% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -271193.649% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 79.009% |
| Denali Therapeutics Inc. | -74.86 Million USD | -2581.591% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -16641.353% |
| Veru Inc. | 4.77 Million USD | 42099.708% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -17751.441% |
| Cingulate Inc. | 3.08 Million USD | 65224.212% |
| Passage Bio, Inc. | 4.58 Million USD | 43885.671% |
| Context Therapeutics Inc. | -14.44 Million USD | -13793.405% |
| Exicure, Inc. | 5.84 Million USD | 34423.354% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -771.433% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -4973.472% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | -230.082% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 12894.424% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -3313.021% |
| Nuvalent, Inc. | -335.38 Million USD | -498.584% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 115854.226% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -2595.38% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -22482.373% |
| OmniAb, Inc. | 9.2 Million USD | 21914.332% |
| Anew Medical, Inc. | 1.43 Million USD | 140248.136% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 12354.932% |
| Lipocine Inc. | -4.75 Million USD | -42123.875% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -1727.925% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 13280.835% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -3862.914% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 8165.133% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -29770.153% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -2949.771% |
| Ocugen, Inc. | -32.52 Million USD | -6073.159% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -2245.981% |
| Q32 Bio Inc. | -37.94 Million USD | -5190.326% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -319577.229% |
| Alumis Inc. Common Stock | -13.52 Million USD | -14739.035% |
| Equillium, Inc. | -22.39 Million USD | -8865.581% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -7751.897% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -6053.147% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -809682.788% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 1597.719% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 62875.891% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 611343.115% |
| Dominari Holdings Inc. | 195 Thousand USD | 1029624.615% |
| Edesa Biotech, Inc. | -5.26 Million USD | -38016.714% |
| vTv Therapeutics Inc. | -8.91 Million USD | -22413.996% |
| Bio-Techne Corporation | 267.74 Million USD | 849.802% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -12285.545% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -1599.979% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -23791.146% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -15768.888% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -719.02% |
| Nkarta, Inc. | 57.29 Million USD | 3603.679% |
| BioCardia, Inc. | 212 Thousand USD | 947068.396% |
| Iterum Therapeutics plc | 13.43 Million USD | 15039.522% |